Free Trial

Anpario (LON:ANP) Stock Crosses Above 200-Day Moving Average - Here's Why

Anpario logo with Consumer Defensive background

Anpario plc (LON:ANP - Get Free Report)'s share price passed above its 200-day moving average during trading on Tuesday . The stock has a 200-day moving average of GBX 335.20 ($4.16) and traded as high as GBX 439 ($5.45). Anpario shares last traded at GBX 427 ($5.30), with a volume of 59,110 shares changing hands.

Wall Street Analyst Weigh In

Separately, Canaccord Genuity Group increased their target price on shares of Anpario from GBX 380 ($4.71) to GBX 500 ($6.20) and gave the company a "buy" rating in a report on Tuesday, January 14th.

Get Our Latest Stock Analysis on ANP

Anpario Stock Performance

The company has a current ratio of 6.15, a quick ratio of 5.16 and a debt-to-equity ratio of 0.21. The stock's 50 day moving average price is GBX 398.64 and its two-hundred day moving average price is GBX 337.86. The firm has a market capitalization of £72.71 million, a PE ratio of 2,388.89 and a beta of 0.58.

Insider Transactions at Anpario

In other news, insider Karen Prior sold 14,000 shares of the firm's stock in a transaction that occurred on Friday, December 13th. The shares were sold at an average price of GBX 380 ($4.71), for a total transaction of £53,200 ($65,988.59). Corporate insiders own 30.51% of the company's stock.

Anpario Company Profile

(Get Free Report)

Anpario plc, together with its subsidiaries, engages in the production and distribution of natural feed additives for animal health, hygiene, and nutrition. Its health and performance category offers various products that support and maintain animal gut health, such as phytogenic and acid based eubiotics, and omega fatty acids under the Orego-Stim, Optomega, pHorce, Salkil, and Genex brands; feed quality category provides products, such as enzymes, antioxidants, pellet binders, mould inhibitors, and acid based eubiotics under the pHorce, Feedzyme, Salgard, Oxigard, Moldgard, and Mastercube brands.

Further Reading

Should You Invest $1,000 in Anpario Right Now?

Before you consider Anpario, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Anpario wasn't on the list.

While Anpario currently has a "Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA Earnings: Will it Spark a Rally or Trigger a Sell-Off?
Marjorie Taylor Greene Bought THOUSANDS in Tesla Stock
The EXACT Date of Next Stock Market Crash

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines